“Miracle Stem Cell ‘Cure’ Could Allow 10 Million Blind To See Again”

Sniffing out the latest teaser from Patrick Cox's Breakthrough Technology Alert

By Travis Johnson, Stock Gumshoe, January 9, 2012

Curing the blind — that sounds lovely, eh? That’s the headline of the latest ad from Patrick Cox …

… we’ve seen many overpromising ads from Cox’s Breakthrough Technology Alert over the years, and they never fail to catch the attention of the great Gumshoe readership. It is, after all, just the kind of thing that newsletter subscribers yearn for: investments that will be so ridiculously successful that your life will be transformed, turning us all into tycoons. And not incidentally, giving us something to brag about while we’re playing golf with old college buddies.

Funny how rarely that transformational wealth actually happens, eh? At least for me. Still, hope bubbles up from underground — and we wouldn’t have it any other way. What fun is life without daydreams?

“And starting today, here’s how you could become richer than you ever imagined by tapping into the explosive $64 BILLION stem cell market…”

This ad brings us several phrases that sound awfully familiar from past ads — not just from this same editor, Patrick Cox of the Breakthrough Technology Alert, but from lots of folks who dabble in biotech. Phrases like …

“It’s a medical breakthrough that is unprecedented in human history….”

And ….

“Could improve and extend the life of every person on earth….”

And

“… one of the most important companies of our time….”

And of course, if we’re to improve and extend every life, there’s riches in them thar hills:

“ONE tiny California-based company, priced under 80 cents per share, has the exclusive rights to this patented new stem cell technology.”

So yep, it’s another life-changing, the world will never be the same, the buckets of cash will rain down like rain from the sky kind of teaser about stem cell technology. Not that there’s anything wrong with that. So who’s he pitching?

Well, it’s one of the “no embryos” stem cell companies — as Cox puts it,

“technology which has the power to ‘cure’ … by rebuilding damaged cells and generating new tissue … without the use of controversial human embryos”

And the eye business? Curing 10 million blind people?

“… scientists at this tiny biotech have developed a patented process that has the potential to create human corneal tissue from their new stem cell technology.”

This technology can apparently create corneal tissue, which would help with the dire shortage of donor corneas.

Cox goes on to quote an expert as saying that most consumers are reluctant to cut back spending on their health even in a bad economy (there are, of course, plenty of folks who can cite facts pointing to the opposite — that elective procedures, in particular, get postponed during weak economic cycles, but certainly big healthcare companies are often considered to be steady and counter-cyclical — or at least, they were before medical investing became so entwined with patent expirations and regulatory upheaval).

But yes, we can stipulate to Cox’s main point, that biotech companies can “soar on new breakthroughs” even if the economy stinks.

And this breakthrough is apparently that someone can take non-embryos and build human stem cells — Cox simplifies it to say that they take an unfertilized egg and “trick it into growing and dividing.”

Thereby sidestepping, he says, all the political and ethical issues that arise when you’re talking about human embryos. He also says that it might solve the problem of immune suppression and prevent rejection of transplanted stem cells. Sounds impressive, no? That is, if you were willing to sit through his looooong “presentation” on this teaser (for whatever reason, Cox’s ads don’t usually let you get at that handy transcript like most publishers do)

Are you getting our free Daily Update
"reveal" emails? If not,
just click here...


And he says they have “multiple clinical trials in the works… for Parkinson’s, liver disease, eye disease, and more.”

And that they’ve “taken the first major step” to build a bank of stem cells in the U.S. — whereby, it sounds like, individualized personal stem cells could be banked for future use.

So what’s the company? Well, I’m sure he’ll tell you if you pony up $895 to subscribe to his newsletter and get his special report (which is subtly entitled, “How to Live Longer, Healthier and Richer with this One Tiny California Company’s Potential Stem Cell Miracle.”)

But if you’re like us, “Free” sounds better than $895″ … so let’s feed those clues into the mighty, mighty Thinkolator and see what our solution is, shall we? Of course, or “free” solution doesn’t come with all the fancy-pants explanations that I presume you would get for nine hundred bucks (I guess they’re not doing too bad, they’ve raised the price from the old “discount” of $695) … but we’ll try to get you started.

guardian — discovery of non-embryo stem cells will “truly revolutionize the treatment of life-threatening illnesses”

A few more clues to toss in …

“$58 million market cap at under 85 cents per share…

“128 international patents or patent applications….”

Then, if you’re willing to sit through the whole “presentation” (we did so, but at the cost of much suffering and fidgeting), you even get a couple bonus clu